These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 27498576

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K.
    World J Gastroenterol; 2015 Apr 28; 21(16):4933-45. PubMed ID: 25945007
    [Abstract] [Full Text] [Related]

  • 3. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S, Rhim H, Kim YS, Kang TW, Song KD.
    Liver Int; 2016 Apr 28; 36(4):580-7. PubMed ID: 26503910
    [Abstract] [Full Text] [Related]

  • 4. The Predictive Power of Serum α-Fetoprotein and Des-γ-Carboxy Prothrombin for Survival Varies by Tumor Size in Hepatocellular Carcinoma.
    Tsugawa D, Fukumoto T, Kido M, Takebe A, Tanaka M, Kuramitsu K, Matsumoto I, Ajiki T, Koyama T, Ku Y.
    Kobe J Med Sci; 2015 Mar 07; 61(5):E124-31. PubMed ID: 27363395
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical Significance of Preoperative Hepatocellular Carcinoma With High Lens culinaris Agglutinin-reactive Fraction of Alpha-Fetoprotein, But Low Alpha-Fetoprotein.
    Yamao T, Yamashita YI, Imai K, Umezaki N, Tsukamoto M, Kitano Y, Arima K, Miyata T, Nakagawa S, Okabe H, Hayashi H, Chikamoto A, Ishiko T, Baba H.
    Anticancer Res; 2019 Feb 07; 39(2):883-889. PubMed ID: 30711971
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma.
    Hakamada K, Kimura N, Miura T, Morohashi H, Ishido K, Nara M, Toyoki Y, Narumi S, Sasaki M.
    World J Gastroenterol; 2008 Mar 07; 14(9):1370-7. PubMed ID: 18322950
    [Abstract] [Full Text] [Related]

  • 12. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T, Orimo T, Wakayama K, Shimada S, Nagatsu A, Yokoo H, Kamachi H, Yamashita K, Shimamura T, Taketomi A.
    World J Surg Oncol; 2017 Aug 22; 15(1):156. PubMed ID: 28830473
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Half-Life of Serum Des-Gamma-Carboxy Prothrombin Is a Prognostic Index of Survival and Recurrence After Liver Resection for Hepatocellular Carcinoma.
    Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, Uesaka K.
    Ann Surg Oncol; 2016 Dec 22; 23(Suppl 5):921-928. PubMed ID: 27638677
    [Abstract] [Full Text] [Related]

  • 15. Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma.
    Kaibori M, Matsui Y, Yanagida H, Yokoigawa N, Kwon AH, Kamiyama Y.
    World J Surg; 2004 Jul 22; 28(7):702-7. PubMed ID: 15185000
    [Abstract] [Full Text] [Related]

  • 16. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
    Pang Q, Zhang JY, Xu XS, Song SD, Qu K, Chen W, Zhou YY, Miao RC, Liu SS, Dong YF, Liu C.
    World J Gastroenterol; 2015 May 14; 21(18):5607-21. PubMed ID: 25987786
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.
    Hayashi M, Shimizu T, Hirokawa F, Inoue Y, Komeda K, Asakuma M, Miyamoto Y, Takeshita A, Shibayama Y, Tanigawa N.
    Am Surg; 2011 May 14; 77(5):572-8. PubMed ID: 21679590
    [Abstract] [Full Text] [Related]

  • 20. Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma.
    Hwang S, Song GW, Lee YJ, Kim KH, Ahn CS, Moon DB, Ha TY, Jung DH, Park GC, Lee SG.
    J Gastrointest Surg; 2016 Nov 14; 20(11):1807-1820. PubMed ID: 27311982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.